Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-α transgenic mice
✍ Scribed by Renold J. Capocasale; Dorie A. Makropoulos; Ram Achuthanandam; Nicole Stowell; John Quinn; Patricia A. Rafferty; Joanne O'Brien; Eva Emmell; Peter J. Bugelski
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 750 KB
- Volume
- 73A
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fanconi anemia (FA) is a genetic syndrome predisposing to hematopoietic failure. Little is known about the pathophysiology of FA, except that tumor necrosis factor-␣ (TNF-␣) is overexpressed in patients. FA group C (Fac) gene knockout mice have been developed in order to model the human disease, but
Although hepatic ischemia-reperfusion (IR) injury is partially mediated by tumor necrosis factor-alpha (TNF), we recently found that low-dose TNF before IR is hepatoprotective. We examined the seemingly conflicting roles of TNF in mediating liver injury in a partial hepatic IR model using TNF gene k